Key result
Primary AVR in octogenarians yields ~70% lower hospital mortality than EuroSCORE predictions.
Why the study?
Does primary aortic valve replacement result in acceptable mortality and long-term survival in patients aged 80 years and older?
Cohort (n=345)
No
Does primary aortic valve replacement result in acceptable mortality and long-term survival in patients aged 80 years and older?
Primary aortic valve replacement in octogenarians is associated with excellent long-term survival and lower hospital mortality than predicted by conventional risk scores.
Answers are grounded in this paper and cite their sources.
Suggests EuroSCORE overestimates risk in octogenarians; leaves open need for updated models before broader adoption.
BACKGROUND: The aging of the population has resulted in an increasing number of elderly patients undergoing cardiac operations. We reviewed our experience in patients over the age of 80 undergoing primary aortic valve replacement (AVR) with or without CABG. METHODS: Between 2000 and 2008, 345 patients (226 male) ≥80 years underwent primary AVR in our unit. The notes of these patients were retrospectively reviewed and follow-up information was obtained from their general practitioners. They had a mean age of 82.9 ± 2.3 years and a median logistic EuroSCORE of 13.4 (IQR 9.4, 19.1). Isolated AVR was performed in 161 patients (45.5%), and 184 (51.6%) patients underwent combined AVR and CABG. A quality of life questionnaire was sent to all survivors. RESULTS: Hospital mortality occurred in 17 patients (4.9%), which was significantly lower than the mortality predicted by logistic EuroSCORE (16.2%, p < 0.01). Hospital mortality was comparable between patients undergoing isolated AVR and those undergoing additional CABG (4.3% vs. 5.4%, respectively). Actuarial survival at one and five years was 90.1 ± 1.6% and 77.2 ± 2.9%, respectively. There was a 62% response on the questionnaire showing 70% of the patients were NYHA I and 83.7% were satisfied with the operation outcome. CONCLUSIONS: AVR can be undertaken with excellent results in octogenarians and the current risk is significantly lower than what is predicted with conventional risk-scoring systems. Patients with advanced age should not necessarily be excluded from being candidates for AVR.
No takes yet. Share an insight, caveat, or question.
Nikolaidis et al. (2011) conducted a cohort in Aortic valve disease requiring replacement (n=345). Primary aortic valve replacement (AVR) with or without CABG vs. Predicted mortality by logistic EuroSCORE was evaluated on Hospital mortality (p=< 0.01). Primary aortic valve replacement in octogenarians resulted in a hospital mortality of 4.9%, lower than the 16.2% predicted by the logistic EuroSCORE.
Synapse has enriched 10 related papers. Consider them for comparative context: